• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Show Coverage: Exchanges face operational challenges

Article

Health insurance exchanges don?t have to be in place until 2014, but states are quickly gearing up for their launch. Dhan Shapurji, director, Deloitte Consulting, along with two of his colleagues, neatly packaged the challenges facing exchanges into nine operational components:

Health insurance exchanges don’t have to be in place until 2014, but states are quickly gearing up for their launch. Dhan Shapurji, director, Deloitte Consulting, along with two of his colleagues, neatly packaged the challenges facing exchanges into nine operational components:

  • Marketing;
  • Products and services;
  • Comparison shopping;
  • Enrollment;
  • Eligibility and subsidy determination;
  • Customer service;
  • Premium reconciliation;
  • Collaboration between stakeholders; and
  • Role of the navigator/advisor.

“Each component has features that potentially affect current legacy operations or may require developing new capabilities and services to help address the needs of businesses on the exchange,” Shapurji said. For example, some plans are contemplating developing a limited network to present a low-cost option for the exchange.

Shapurji explored four major issues associated with the operational factors–channel disruption, financing and reconciliation, eligibility dynamics and the customer experience, the latter two affected by the growing number of persons who will enter the insurance pool.

“We know that health exchanges will be transformational, ” Shapurji said. “We anticipate seeing variability in models among states, which will need to offer different levels of benefits in order to create a competitive environment and keep premiums down. There are still many questions left on the table, from information interoperability to premiums and the delivery of services. ”

Shapurji foresees that state exchanges will look to HHS for guidance on how household income will be calculated and monitored for subsidy eligibility; who will undertake premium collection, reconciliation and determine disenrollment if the premium is not paid; and what mechanisms will be established to smoothly transfer customers between products and services.

He noted that plans also have to prepare themselves by determining which markets they are going to compete in and what type of competition they will face. Once they determine the scope of their markets, they can analyze the types of services and capabilities required to compete.

Related Videos
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Related Content
© 2024 MJH Life Sciences

All rights reserved.